Evidence map›Paper›PMID 42353204›Full record

ReviewInternational journal of molecular sciences2026

From Tradition to Translation: A Critical Appraisal of

Abosede Temitope Olajide, Sasithon Aunsorn, Samuel Abiodun Kehinde, Thammarat Kaewmanee, Sasitorn Chusri

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abosede Temitope OlajideBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0000-0003-4813-123X
Sasithon AunsornDepartment of Thai Traditional Medicine, Faculty of Allied Health Sciences, Nakhon Ratchasima College, Nakhon Ratchasima 30000, Thailand.ORCID 0009-0008-5025-4590
Samuel Abiodun KehindeBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0000-0003-3768-906X
Thammarat KaewmaneeDepartment of Food Science and Nutrition, Faculty of Science and Technology, Prince of Songkla University, Pattani 94000, Thailand.ORCID 0000-0002-6065-3287
Sasitorn ChusriBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0000-0002-7365-6890

Funding

National Science, Research, and Innovation Fund (NSRF) and Mae Fah Luang University (Fundamental Fund Grant) 67A307000040
6 · The paper itself

Abstract

Dementia, and more specifically Alzheimer's disease (AD), is a progressive neurodegenerative disorder that has become a growing health menace in the world with an escalation in incidence as well as enormous social and economic consequences. Existing pharmacological treatment including cholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists are not very effective in reducing the symptoms and fail to prevent the disease process. The non-pharmacological treatment interventions such as diet, exercise and cognitive training have supportive effects and cannot be used as standalone treatments. Therapeutic gap has resulted in increased interest in complementary and alternative therapies, especially that of pleiotropic action of herbal medicines.

Indexed as

Alzheimer DiseaseBacopaNeuroprotectionNeuroprotective AgentsPlant ExtractsAnimalsCognitive EnhancementHumansNeuroprotective AgentsPlant ExtractsAlzheimer’s diseaseBacopa monnieribacosidescognitive enhancementdementia

Identifiers

PMID42353204
PMCPMC13300590

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.